News of Note—Teva strikes labor agreement at Israeli plant

Woman typing on computer
(Max Pixel/CC0)

> Aurobindo this week reported that it has completed its €74 acquisition of generic and OTC drugs from Apotex in five European countries. The Hindu article

> Teva has completed a union agreement covering the 1,200 employees at its Kfar Saba plant in Israel that runs through 2019 and grants them a 2.2% raise. Globes artlcle

> Immunomedics, which received a CRL in January tied to its manufacturing plant in New Jersey, reported that it expects to sit down with the FDA after receiving an establishment inspection report for the facility. Filing

Webinar This Week

OTC Innovation to Avoid Stagnation: Survey Insights, Expert Advice, and Latest Technologies to Boost Your Product’s Performance

Join us for a complimentary webinar on November 13 at 11am ET / 8am PT. Listen to industry experts as they analyze the critical role of innovation in OTC products, and strategies for achieving it.

> WuXi Biologics and Amicus Therapeutics have struck an exclusive commercial manufacturing partnership for Amicus' Pompe biologic ATB200. Release

Suggested Articles

Lonza CEO Marc Funk is leaving for "personal reasons" after less than a year in the top job. 

Drugmakers have voluntarily recalled their generic Zantac from the U.S. market after the FDA raised concerns, but it has not been without a cost.

Just weeks after selling the sterile manufacturing assets of its Kyowa operation in Japan, it has unloaded the rest of its Kyowa drugmaking operation.